Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Expands Its San Francisco Bay Area Operations: Opens New Office to Support Life Sciences Firms

HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO),...

Veristat Growth and Service Demand Drive Expansion: Veristat to Move Corporate Headquarters

Veristat will Move Corporate Headquarters to Southborough, MA This Summer

Veristat to Assist on Adaptive Enrichment Design Trial for Verastem’s Defactinib in Mesothelioma

Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program

September...

Veristat’s Collaboration with Aegerion Contributes to FDA Approval of Juxtapid™

Veristat’s Strategic Guidance Contributes to Successful Approval of Aegerion’s Novel Drug Juxtapid

Variance Development Partners Makes a Growth Investment in Veristat

Investment Will Enable Veristat to Further Enhance its Market Leadership Position and...